Treatment outcomes of unresectable hepatocellular carcinoma by transarterial chemoembolisation combined with radiofrequency ablation

Hepatocellular carcinoma (HCC) is one of the most common cancer and ranks third in terms of cancer related deaths. The purpose of this study was to evaluate the effectiveness and survival benefits of the TACE+RFA approach to the management of unresectable HCCs in Hue Central Hospital, Vietnam.